BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 19222471)

  • 1. The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.
    Maserati E; Pressato B; Valli R; Minelli A; Sainati L; Patitucci F; Marletta C; Mastronuzzi A; Poli F; Lo Curto F; Locatelli F; Danesino C; Pasquali F
    Br J Haematol; 2009 Apr; 145(2):190-7. PubMed ID: 19222471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies.
    Maserati E; Minelli A; Pressato B; Valli R; Crescenzi B; Stefanelli M; Menna G; Sainati L; Poli F; Panarello C; Zecca M; Curto FL; Mecucci C; Danesino C; Pasquali F
    Genes Chromosomes Cancer; 2006 Apr; 45(4):375-82. PubMed ID: 16382447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.
    Minelli A; Maserati E; Nicolis E; Zecca M; Sainati L; Longoni D; Lo Curto F; Menna G; Poli F; De Paoli E; Cipolli M; Locatelli F; Pasquali F; Danesino C
    Leukemia; 2009 Apr; 23(4):708-11. PubMed ID: 19148133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
    Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
    Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isochromosome 5p and related anomalies: a novel recurrent chromosome abnormality in myeloid disorders.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Guéganic N; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Jul; 200(2):134-9. PubMed ID: 20620596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies.
    MacKinnon RN; Campbell LJ
    Cancer Genet Cytogenet; 2005 Dec; 163(2):176-9. PubMed ID: 16337864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SBDS mutations and isochromosome 7q in a patient with Shwachman-Diamond syndrome: no predisposition to malignant transformation?
    Mellink CH; Alders M; van der Lelie H; Hennekam RH; Kuijpers TW
    Cancer Genet Cytogenet; 2004 Oct; 154(2):144-9. PubMed ID: 15474150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia.
    Majeed F; Jadko S; Freedman MH; Dror Y
    Pediatr Blood Cancer; 2005 Dec; 45(7):920-4. PubMed ID: 16007594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
    Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
    Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isochromosome (7)(q10) in Shwachman syndrome without MDS/AML and role of chromosome 7 anomalies in myeloproliferative disorders.
    Maserati E; Minelli A; Olivieri C; Bonvini L; Marchi A; Bozzola M; Danesino C; Scappaticci S; Pasquali F
    Cancer Genet Cytogenet; 2000 Sep; 121(2):167-71. PubMed ID: 11063802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome.
    Lizcova L; Zemanova Z; Malinova E; Jarosova M; Mejstrikova E; Smisek P; Pospisilova D; Stary J; Michalova K
    Cancer Genet Cytogenet; 2010 Aug; 201(1):52-6. PubMed ID: 20633770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
    Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
    Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.